Access to Plasma-Derived Medicinal Products in Low and Middle Income Countries Through Processing of Domestic Plasma
Program Date: 18 January 2022
Publication Date: 10 February 2022
Continuing Education Units: Hours: 1.0
Lecture Description:
In this lecture, Thierry Burnouf will present on access to plasma-derived medicinal products in low- and middle-income countries through the processing of domestic plasma.Lecture Objectives:
• Summarize the therapeutic importance of plasma products.
• State points to consider when building a domestic plasma fractionation facility.
• Review stepwise pragmatic approaches to improve the safety of therapeutic plasma proteins.
- Run Time: 34
Lecture Instructor Bio(s)
Thierry Burnouf, PhD
Taipei Medical University
Vice-Dean, College of Biomedical Engineering
Thierry Burnouf has a long experience with the plasma fractionation industry and research on therapeutic plasma products purification and virus inactivation, with over 250 scientific publications. He is the Secretary of the Working Party on Global Blood Safety, the Treasurer of the Working Party on Cellular Therapies of the International Society of Blood Transfusion. Recently, he has served as the Chair of the drafting group of the “WHO Guidance on Increasing Supplies of Plasma-Derived Medicinal Products in Low- and Middle-Income Countries through fractionation of Domestic Plasma.”
Completed a Lecture?
FREQUENTLY ASKED QUESTIONS